Gotu kola, kava kava, St. John's wort, valerian may increase CNS depression. **FOOD:** None known. **LAB VALUES:** May decrease total free thyroxine (T<sub>4</sub>) serum levels. May increase serum cholesterol, triglycerides, ALT, AST, WBC, GGT. May produce false-positive pregnancy test result.

**AVAILABILITY (Rx)**

**Tablets:** 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg.

**Tablets, Extended-Release:** 50 mg, 150 mg, 200 mg, 300 mg, 400 mg.

**ADMINISTRATION/HANDLING**

**PO**

- Give immediate-release tablets without regard to food.  
- Do not break, crush, dissolve, or divide extended-release tablets.  
- Extended-release tablets should be given without regard to food or with a light meal in evening.

**INDICATIONS/ROUTES/DOSAGE**

**Note:**  
- When restarting pts who have been off QUEtapine for less than 1 wk, titration is not required and maintenance dose can be reinstalled.  
- When restarting pts who have been off QUEtapine for longer than 1 wk, follow initial titration schedule.  
- When discontinuing, gradual tapering recommended to avoid withdrawal symptoms and minimize risk of relapse.

**Schizophrenia**

**PO:**  
**(Immediate-Release):** **ADULTS, ELDERLY:** Initially, 25 mg twice daily, then increase in 25–50 mg increments divided 2–3 times/day on the second and third days, up to 300–400 mg/day in 2–3 divided doses by the fourth day. Further adjustments of 25–50 mg twice daily may be made at intervals of 2 days or longer. **Maintenance:** 150–750 mg/day (adults); 50–200 mg/day (elderly).  

**(Extended-Release):** Initially, 300 mg/day. May increase at intervals as short as 1 day up to 300 mg/day. Range: 400–800 mg/day.  

**(Immediate-Release):** **CHILDREN**

**Depression in Bipolar Disorder**

**PO:**  
**(Immediate-Release):** **ADULTS, ELDERLY:** Initially, 50 mg/day on day 1, increase to 100 mg/day on day 2, then increase by 100 mg/day up to target dose of 300 mg/day. (Extended-Release): Initially, 50 mg on day 1 in the evening, 100 mg on day 2, 200 mg on day 3, 300 mg on day 4 and thereafter.

**Adjunctive Therapy in MDD**

**PO:** **ADULTS, ELDERLY:** (Extended-Release): Initially, 50 mg on days 1 and 2; then 150 mg on days 3 and 4; then 150–300 mg/day thereafter.